Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Eur J Gynaecol Oncol ; 35(2): 170-3, 2014.
Article in English | MEDLINE | ID: mdl-24772922

ABSTRACT

Ovarian cancer usually spreads into abdominal cavity and to the loco-regional lymph nodes. Extra-abdominal metastases are less frequent and isolated axillary metastases are very rare. The authors describe the case of a 49-year-old woman who was diagnosed with a peritoneal carcinomatosis from ovarian cancer by mean of an enlarged axillary lymph node biopsy, whose histological examination identified as a ovarian cancer metastasis. Patient was treated by peritonectomy and intraperitoneal chemohyperthermic perfusion (HIPEC). Although patients with axillary lymph node metastasis from ovarian cancer are though to be metastatic (FIGO Stage IV), surgical radical treatment and adjuvant systemic chemotherapy can achieve the same prognosis of Stage IIIb-c patients, suggesting they could be a particularly good prognosis subset of patients. Early differential diagnosis between ovarian or breast cancer in axillary lymph node metastasis is crucial but not always very simple, because of the very different course and treatment of these tumours.


Subject(s)
Adenocarcinoma, Papillary/pathology , Carcinoma/secondary , Lymph Nodes/pathology , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/secondary , Axilla , Female , Humans , Lymphatic Metastasis , Middle Aged
2.
Eur J Gynaecol Oncol ; 19(2): 123-5, 1998.
Article in English | MEDLINE | ID: mdl-9611049

ABSTRACT

The need of foreseeing the prognosis of ovarian cancer beyond the limits of classical methods based on clinical and histopathological staging has recently caused great interest in a large number of biologic prognostic markers. Studies concern proliferation associated proteins, suppressor genes, abnormal expressions of growth factors, cytokins, and many more. Here some of the most recent and promising factors being studied are described together with their significance for future clinical application.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma/diagnosis , Ovarian Neoplasms/diagnosis , Carcinoma/chemistry , Carcinoma/mortality , Female , Gene Expression Regulation , Humans , Immunohistochemistry , Neoplasm Staging , Ovarian Neoplasms/chemistry , Ovarian Neoplasms/mortality , Point Mutation , Prognosis , Sensitivity and Specificity , Survival Rate , Tumor Cells, Cultured/chemistry
3.
Rev Saude Publica ; 30(4): 358-63, 1996 Aug.
Article in Portuguese | MEDLINE | ID: mdl-9201897

ABSTRACT

This is a cross-sectional study with a randomized choice of individuals aiming at studying the validity of the Brazilian biological exposure limits applied to lead level in the blood (PbB) and delta-aminolevulinic acid in the urine (ALAU), which are 60 mu/dl and 10 mg/g.creat., respectively. Thus, twenty workers, whose PbB and ALAU values have been below these limits over the past two years, were selected at random at a battery plant in the State of S. Paulo, Brazil. The workers were submitted to a variation of the WHO Neurobehavioral Core Test Battery. The results were compared with those obtained for workers of a control group also chosen at random. The lead workers showed memory, mood and motor coordination disorders. Comparing these results with those obtained from the control group, a significant difference was observed (p-value < 0.02). The results indicate that the Brazilian biological exposure limits above should be reconsidered.


Subject(s)
Lead/blood , Mental Disorders/blood , Nervous System Diseases/blood , Occupational Exposure , Cross-Sectional Studies , Humans
4.
Minerva Ginecol ; 47(9): 349-53, 1995 Sep.
Article in Italian | MEDLINE | ID: mdl-8545034

ABSTRACT

Gn-RH analogues have been recently employed for the treatment of oestrogen-dependent benign gynaecological disorders, such as uterine myomata, endometriosis or metrorrhagia. They induce a "pharmacological castration", inducing a marked reduction of serum oestrogen levels. They proved more effective than other drugs used up to now in the medical treatment of these benign gynaecological diseases. Thus they were initially employed in every case. Later it became clear that Gn-RH analogues need a selective indication. The authors herein report their series of 70 patients with benign gynaecological disorders (45 uterine fibroids, 10 endometriosis, 15 metrorrhagia), treated with a Gn-RH analogue depot for 2-3 months preoperatively. They evaluated the efficacy of the treatment in the group with uterine fibroids in terms of disappearance of metrorrhagia, better haemoglobin level in anaemic patients, reduction of fibroids size allowing for a simpler and less extensive surgery (vaginal surgery, myomectomy, hysteroscopic resection). The authors discuss those cases when preoperative treatment with Gn-RH analogues is not indicated, or should be employed only under careful surveillance (in the preparation of multiple myomectomies, big submucosal myomas). In the group of 10 patients with endometriosis we observed the disappearance of pelvic pain and dyspareunia, whereas the size of endometriomas was only minimally reduced. The authors discuss the usefulness of this treatment in case of patients with endometriosis grade I or II (minimal or mild), with desire of children. In the group of 15 perimenopausal patients with metrorrhagia, 10 became amenorrhoic after termination of treatment, thus avoiding surgery. The major benefit for the other 5 patients was a better haemoglobin level at the time of surgery.


Subject(s)
Genital Diseases, Female/drug therapy , Gonadotropin-Releasing Hormone/analogs & derivatives , Endometriosis/drug therapy , Endometriosis/surgery , Female , Genital Diseases, Female/surgery , Genital Neoplasms, Female/drug therapy , Genital Neoplasms, Female/surgery , Gonadotropin-Releasing Hormone/therapeutic use , Humans , Leiomyoma/drug therapy , Leiomyoma/surgery , Metrorrhagia/drug therapy , Metrorrhagia/surgery
5.
Clin Exp Obstet Gynecol ; 21(1): 30-2, 1994.
Article in English | MEDLINE | ID: mdl-8020174

ABSTRACT

The authors report their experience in medical and surgical complications after surgical treatment of endometrial carcinoma, from January 1976 to December 1992, 301 cases of adenocarcinoma were operated by abdominal or vaginal route. From 1980 onwards abdominal route was the most frequent (radical hysterectomy with bilateral adnexectomy Rutledge type II-III with pelvic and/or aortic lymphadenectomy). No lesion occurred either during surgery or later, in the urinary or intestinal apparatus or to the great abdomino-pelvic vessels. The only medical complication observed was one episode of cerebral ictus three days after operation. Two cases of adynamic ileus and five of ventral hernia occurred.


Subject(s)
Adenocarcinoma/surgery , Endometrial Neoplasms/surgery , Postoperative Complications , Female , Humans , Hysterectomy , Hysterectomy, Vaginal , Lymph Nodes/surgery
6.
Eur J Gynaecol Oncol ; 15(2): 115-8, 1994.
Article in English | MEDLINE | ID: mdl-8005139

ABSTRACT

Ultrasound, hysteroscopy and magnetic resonance imaging has been considerated to assess the loco-regional or extrapelvic extension of the endometrial carcinoma. Sonography has demonstrated a certain inaccuracy in predicting myometrial invasion or the involvement of the canal. Hysteroscopy allows us to characterize neoplasia and to assess its extension in the cervical canal. MR imaging is more helpful in the diagnosis of channel invasion. The assessment of ovarian metastasis requires ultrasonography or coronal planes RM imaging. As regards the involvement of the pelvic and extrapelvic lymph nodes MR is more accurate than ultrasound scan.


Subject(s)
Adenocarcinoma/pathology , Endometrial Neoplasms/pathology , Neoplasm Staging/methods , Adenocarcinoma/diagnostic imaging , Aged , Endometrial Neoplasms/diagnostic imaging , Female , Humans , Hysteroscopy , Magnetic Resonance Imaging , Middle Aged , Preoperative Care , Sensitivity and Specificity , Ultrasonography
8.
Eur J Gynaecol Oncol ; 14(6): 501-5, 1993.
Article in English | MEDLINE | ID: mdl-8181489

ABSTRACT

Research of bone marrow micrometastases in patients with breast cancer was proposed as a prognostic factor in order to detect those patients at high risk for early recurrence. The Authors present a review of current literature and describe the different methods used, with particular regard to monoclonal antibodies. The biological significance and prognostic value of the presence of bone marrow micrometastases in clinically Mo patients with breast cancer are discussed.


Subject(s)
Bone Marrow/pathology , Breast Neoplasms/pathology , Bone Marrow/ultrastructure , Female , Humans , Neoplasm Metastasis , Prognosis
9.
Clin Exp Obstet Gynecol ; 20(3): 151-8, 1993.
Article in English | MEDLINE | ID: mdl-8403422

ABSTRACT

The incidence of epithelial ovarian cancer reaches a peak between the ages of 50 and 59 years. Therefore any ovarian enlargement in the postmenopause has been treated up to now with prompt surgical exploration. Recently the reliability of ultrasound has allowed a conservative management of small unilocular ovarian cysts even in the postmenopause. The Authors report here their experience on benign masses in postmenopausal women, and discuss the feasibility of ultrasound-guided aspiration of small, anechoic adnexal cysts.


Subject(s)
Ovarian Cysts/surgery , Postmenopause , Female , Humans , Middle Aged , Ovarian Cysts/diagnostic imaging , Ovarian Cysts/pathology , Suction , Ultrasonography
10.
Clin Exp Obstet Gynecol ; 20(2): 116-9, 1993.
Article in English | MEDLINE | ID: mdl-8330432

ABSTRACT

Tamoxifen used for adjuvant therapy in breast cancer, has a complex and unclear action on endometrium and myometrium. Many authors demonstrated endometrial proliferous changes in peri and post menopausal women. Our study shows the development of myomas in three patients without uterine pathology before tamoxifen therapy, and the increase of a polip and a myoma after tamoxifen therapy. Moreover, we observed the development of a myoma in a patient after one year tamoxifen in association with LH-RH analogue therapy. It is necessary to continue our study with a larger number of patients to assess the hyperplasic effect of tamoxifen.


Subject(s)
Tamoxifen/adverse effects , Uterine Neoplasms/chemically induced , Uterus/pathology , Adult , Aged , Endometrial Neoplasms/chemically induced , Female , Humans , Hyperplasia/chemically induced , Middle Aged , Myoma/chemically induced , Polyps/chemically induced , Tamoxifen/therapeutic use
11.
Clin Exp Obstet Gynecol ; 20(4): 236-40, 1993.
Article in English | MEDLINE | ID: mdl-8281705

ABSTRACT

Microcolposcopy is a microscopic examination which permits the observation of in vivo normal and dysplastic cells. A comparison was made between colposcopy and microcolposcopy in terms of sensitivity, specificity and predictive value in the diagnosis of cervical intraepithelial neoplasia. Seventy-eight patients with abnormal cervical smears were submitted to colposcopy, microcolposcopy and one or more biopsies on the microcolposcopically suspected areas. Currents classifications were used for the colposcopy and microcolposcopy. A comparison was made between the colposcopic description of abnormal transformation zone, and the microcolposcopic grade 2. The findings suggests that microcolposcopy is more sensitive and has more diagnostic accuracy than colposcopy in the diagnosis of cervical intraepithelial neoplasia. Microcolposcopy is a good alternative to colposcopy in evaluating abnormal cervical cytology.


Subject(s)
Colposcopy/methods , Papanicolaou Test , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Vaginal Smears/methods , Adult , Evaluation Studies as Topic , Female , Humans , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity
13.
Eur J Gynaecol Oncol ; 13(1 Suppl): 40-4, 1992.
Article in English | MEDLINE | ID: mdl-1511713

ABSTRACT

Malignant tumours of the breast occurring as cysts present an incidence from 0.3% to 0.7%. The Authors report their experience during 15 years in 470 patients with carcinoma of the breast. Endocystic carcinoma appeared in 0.6% of patients: the diagnosis is not always possible with cytology, but ultrasound scans make possible to identiphy cysts which have to undergo biopsy because solid areas within the cystic cavity have been detected. In this case surgery is advised even if the cytological examination has been negative.


Subject(s)
Breast Neoplasms/pathology , Carcinoma/pathology , Adult , Aged , Breast Neoplasms/diagnostic imaging , Carcinoma/diagnostic imaging , Cysts/diagnostic imaging , Cysts/pathology , Female , Humans , Middle Aged , Ultrasonography
15.
Eur J Gynaecol Oncol ; 12(6): 463-9, 1991.
Article in English | MEDLINE | ID: mdl-1809579

ABSTRACT

The authors evaluate the diagnostic role of hysteroscopy and sonography in the early detection of endometrial cancer. In their experience diagnostic accuracy of transabdominal ultrasound was 87.5%; the introduction of transvaginal sonography increased it up to 95.8%, whereas hysteroscopy had diagnostic accuracy of 100%. The hysteroscopy allowed us to establish cervical canal involvement in 100% of cases. Since sonography is well accepted by patients, the authors propose to perform it in high risk patients once a year as a first level exam to show abnormal endometrial echoes. Therefore patients can be selected to undergo hysteroscopy and, if necessary, biopsy.


Subject(s)
Adenocarcinoma/diagnosis , Uterine Neoplasms/diagnosis , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/pathology , Aged , Biopsy , Diagnosis, Differential , Endoscopy , Female , Humans , Middle Aged , Sensitivity and Specificity , Ultrasonography/methods , Uterine Diseases/diagnosis , Uterine Diseases/diagnostic imaging , Uterine Hemorrhage/etiology , Uterine Neoplasms/complications , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology
16.
G Ital Oncol ; 9(1): 35-8, 1989.
Article in Italian | MEDLINE | ID: mdl-2707837

ABSTRACT

The Authors report their experience on the vulvar carcinoma therapy. Patients showed, with high frequency, hypertension and diabetes. The 25.9% of the patients, furthermore, were obese. The surgery was the primary treatment, combined with chemiotherapy and radiotherapy in selected cases. The survival rate was 80% in I stage, while in the III and IV stage was very low, in spite of the use of chemotherapy.


Subject(s)
Adenocarcinoma/therapy , Carcinoma, Squamous Cell/therapy , Vulvar Neoplasms/therapy , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Humans , Middle Aged , Prognosis
17.
Gynecol Oncol ; 25(2): 244-9, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3019845

ABSTRACT

Clinical use of cis-platinum in the treatment of many human tumors is increasing. Since side effects could represent a limitation of its use, we evaluated neurotoxic effects of this compound in a group of 23 patients on antiblastic treatment for gynecological neoplasms. Evaluation was performed by clinical-neurological examination, neurophysiological data (electromyography, maximal motor conduction velocity, and sensory conduction velocity) and potentials. Seven patients reported subjective symptoms of neurological involvement. In 2 cases there was a change in the electromyographic pattern. The otolaryngological examination showed a change in the hearing threshold in 3 patients and in 1 case the fatigue test was positive. Neurotoxic effects and hearing damage was not related to the treatment schedule.


Subject(s)
Cisplatin/adverse effects , Hearing Disorders/chemically induced , Peripheral Nervous System Diseases/chemically induced , Adolescent , Adult , Aged , Audiometry , Carcinoma/drug therapy , Choriocarcinoma/drug therapy , Cisplatin/administration & dosage , Electromyography , Female , Humans , Middle Aged , Ovarian Neoplasms/drug therapy , Peripheral Nervous System Diseases/physiopathology , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...